Healthpeak Properties (NYSE:DOC) Hits New 1-Year Low – Time to Sell?

Healthpeak Properties, Inc. (NYSE:DOC) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $15.93 and last traded at $15.9650, with a volume of 405654 shares trading hands. The stock had previously closed at $15.99.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Robert W. Baird cut their target price on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Wells Fargo & Company lifted their price target on Healthpeak Properties from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Monday, September 15th. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Monday, December 15th. Finally, Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $17.00 in a report on Monday, December 15th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.18.

Healthpeak Properties Trading Up 0.3%

The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. The company’s fifty day moving average price is $17.65 and its two-hundred day moving average price is $17.82. The firm has a market cap of $11.15 billion, a PE ratio of -320.84, a P/E/G ratio of 4.05 and a beta of 1.11.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The firm had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same period in the prior year, the company posted $0.45 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) annualized dividend and a yield of 7.6%. Healthpeak Properties’s dividend payout ratio is presently -2,440.00%.

Hedge Funds Weigh In On Healthpeak Properties

A number of large investors have recently made changes to their positions in the stock. State Street Corp increased its holdings in Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after buying an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. Geode Capital Management LLC raised its holdings in Healthpeak Properties by 1.0% during the second quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock worth $332,625,000 after purchasing an additional 197,540 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Healthpeak Properties by 2.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock worth $184,208,000 after purchasing an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC boosted its position in Healthpeak Properties by 6.7% during the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock worth $195,960,000 after purchasing an additional 641,771 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.